Despite a decade cancer-free, a new breast cancer diagnosis led to a bilateral mastectomy and later chemotherapy and ...

Tecvayli and Darzalex combination shows unprecedented progression-free survival in relapsed/refractory multiple myeloma, ...

At Keck Medicine of USC, surgeons, oncologists and radiation specialists collaborate closely, ensuring individualized care ...

The author's journey through multiple myeloma was supported by medical professionals, family, and community, emphasizing the ...

The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune ...

Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...

Joe McDonough reflects on the bonds he’s formed in the childhood cancer community and what they’ve taught him about empathy ...

My name is Beth Kramer, and I am 58 years old. Over the past 15 years, I have faced the life-altering words, “you have cancer,” not once, but three times.

The American Cancer Society’s 2026 Cancer Statistics report shows the five-year survival rate for all cancers has reached a ...

Kyle Donahue, who was given months to live after receiving a diagnosis of glioblastoma in 2021, enrolled in a clinical trial ...

A new HER2-targeted regimen may push survival closer to two years for some patients with gastroesophageal cancer, according ...

Dr. Benjamin Jon Golas of Hackensack Meridian Health discussed the main strategies for treating pancreas cancer, focusing on ...